Bupropion Hydrochloride SR
NDC 50228-174, bupropion hydrochloride, tablet, film coated, extended release, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-174
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205794
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPROPION HYDROCHLORIDE100 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-174-01 | 50228017401 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-01) |
| 50228-174-05 | 50228017405 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-05) |
| 50228-174-10 | 50228017410 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-10) |
| 50228-174-30 | 50228017430 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-30) |
| 50228-174-60 | 50228017460 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-174-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/092da413-ec60-4577-ac57-51e3e42d55c9NADAC price for package 50228017401
GET /v1/drugs/nadac/50228017401NADAC price for package 50228017405
GET /v1/drugs/nadac/50228017405NADAC price for package 50228017460
GET /v1/drugs/nadac/50228017460
Use it
Look up 50228-174 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.